A new β-caryophyllene type sesquiterpenoid pentoside with nine known compounds from the aerial parts of Biebersteinia heterostemon as a α-glucosidase inhibitor in vitro
Yu-hao Zhang , Deng-yi Du , Ruo-fei Bai , Cong-wei Zhou , Zi-jian Zhao , Shan-shan Yang
{"title":"A new β-caryophyllene type sesquiterpenoid pentoside with nine known compounds from the aerial parts of Biebersteinia heterostemon as a α-glucosidase inhibitor in vitro","authors":"Yu-hao Zhang , Deng-yi Du , Ruo-fei Bai , Cong-wei Zhou , Zi-jian Zhao , Shan-shan Yang","doi":"10.1016/j.phytol.2025.102956","DOIUrl":null,"url":null,"abstract":"<div><div>To elucidate the chemical basis of the hypoglycemic activity of <em>Biebersteinia heterostemon</em> Maxim, a Tibetan folk medicinal herb, a new <em>β</em>-caryophyllene type sesquiterpenoid pentoside (<strong>1</strong>) and nine known compounds (<strong>2</strong>–<strong>10</strong>) were isolated from its aerial part, and their structures were identified by the use of UV, NMR and HR-MS analyses. Significantly, the compound <strong>1</strong> was isolated from this plant for the first time in the form of a pentaglycoside. The results of <em>α</em>-glucosidase inhibitory activity assays indicated that the compound <strong>1</strong>, ethyl acetate fraction, compound <strong>2</strong> and remaining aqueous fraction exhibited weak inhibitory activity, with IC<sub>50</sub> values of 2.46, 3.59, 4.87 and 5.03 mg/mL, respectively, all of which were weaker inhibitory activity than that of the positive control, acarbose (IC<sub>50</sub> = 0.78 mg/mL). Among the tested samples, compound <strong>1</strong> displayed the most promising inhibitory activity, with an inhibition rate of 70.90 ± 6.07 % at a concentration of 5.0 mg/mL. In contrast, among the other isolated compounds, especially the flavonoid compounds (<strong>5–10</strong>), some showed low inhibitory activities, while others showed no inhibitory activity at all.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"67 ","pages":"Article 102956"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025010456","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
To elucidate the chemical basis of the hypoglycemic activity of Biebersteinia heterostemon Maxim, a Tibetan folk medicinal herb, a new β-caryophyllene type sesquiterpenoid pentoside (1) and nine known compounds (2–10) were isolated from its aerial part, and their structures were identified by the use of UV, NMR and HR-MS analyses. Significantly, the compound 1 was isolated from this plant for the first time in the form of a pentaglycoside. The results of α-glucosidase inhibitory activity assays indicated that the compound 1, ethyl acetate fraction, compound 2 and remaining aqueous fraction exhibited weak inhibitory activity, with IC50 values of 2.46, 3.59, 4.87 and 5.03 mg/mL, respectively, all of which were weaker inhibitory activity than that of the positive control, acarbose (IC50 = 0.78 mg/mL). Among the tested samples, compound 1 displayed the most promising inhibitory activity, with an inhibition rate of 70.90 ± 6.07 % at a concentration of 5.0 mg/mL. In contrast, among the other isolated compounds, especially the flavonoid compounds (5–10), some showed low inhibitory activities, while others showed no inhibitory activity at all.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.